Home › Funds › BARR E S & CO › JNJ

BARR E S & CO position in JNJ

JOHNSON & JOHNSON · Health Care

BARR E S & CO reported holding 112,230 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$29.7M, representing 1.74% of its reported portfolio and ranking #19 among its reported holdings. BARR E S & CO has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)112.23K sh
Reported value held$29.71M
Portfolio Weight1.74%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BARR E S & CO's JNJ position evolved

BARR E S & CO first disclosed a stake in JNJ in Q3 2023 at 185,738 shares (US$28.9M). The position peaked in Q3 2026 at 112,230 shares, worth US$29.7M. Across 13 filings, BARR E S & CO increased the stake 0 time(s), trimmed it 12 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 112,230 shares valued at US$29.7M — a reduction of -2,825 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 185.74K $28.93M New
Q4 2023 179.34K $28.11M Reduce
Q1 2024 168.35K $26.63M Reduce
Q2 2024 163.04K $23.83M Reduce
Q3 2024 159.19K $25.80M Reduce
Q4 2024 150.51K $21.77M Reduce
Q1 2025 141.09K $23.40M Reduce
Q2 2025 132.42K $20.23M Reduce
Q3 2025 124.68K $23.12M Reduce
Q4 2025 122.83K $25.42M Reduce
Q1 2026 119.07K $29.10M Reduce
Q2 2026 115.06K $29.22M Reduce
Q3 2026 112.23K $29.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has BARR E S & CO held JNJ?

BARR E S & CO has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BARR E S & CO's current position in JNJ?

As of Q3 2026, BARR E S & CO holds 112.23K shares of JNJ (JOHNSON & JOHNSON), valued at $29.71M, representing 1.74% of its reported portfolio and ranking #19.

Has BARR E S & CO been buying or selling JNJ?

In the latest 13F filing (Q3 2026), BARR E S & CO reduced its position in JNJ. The position peaked in Q3 2026 at 112.23K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.